MedTrace Logo

A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure)

NCT02483364 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-03-17

No results posted yet for this study

Summary

The purpose os this study is to evaluate the safety and effectiveness of HC-SVT-1001 and HC-SVT-1002 in the surgical treatment of atrophic nonunion in long bones.

Conditions

  • Pseudoarthrosis

Interventions

OTHER

HC-SVT-1001(initial protocol); HC-SVT-1002 (protocol amendment)

A single application in the context of a single surgical intervention.

Sponsors & Collaborators

  • Salvat

    lead INDUSTRY

Principal Investigators

  • Enrique Jimenez, MD · Laboratorios Salvat

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-10
Primary Completion
2020-05-18
Completion
2020-10-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02483364 on ClinicalTrials.gov